Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190)
22.64
+0.04 (0.18%)
Apr 29, 2026, 4:08 PM HKT
HKG:2190 Revenue
In the year 2025, Zylox-Tonbridge Medical Technology had annual revenue of 1.06B CNY with 35.15% growth. Zylox-Tonbridge Medical Technology had revenue of 575.52M in the half year ending December 31, 2025, with 93.37% growth.
Revenue
1.06B CNY
Revenue Growth
+35.15%
P/S Ratio
6.44
Revenue / Employee
1.14M CNY
Employees
925
Market Cap
7.58B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Beijing Chunlizhengda Medical Instruments | 1.16B |
| AK Medical Holdings | 1.65B |
| LifeTech Scientific | 1.52B |
| China Isotope & Radiation | 8.00B |
| MicroPort NeuroScientific | 879.66M |
| Peijia Medical | 793.29M |
| Jenscare Scientific | 100.81M |
| LEPU ScienTech Medical Technology (Shanghai) | 587.50M |